{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-097086","form_type":"8-K","ticker":null,"cik":"0001834645","company_name":"Peak Bio, Inc.","filed_at":"2024-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.795473+00:00","generated_at":"2026-05-31T09:24:25.939149+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Peak Bio appoints Sandip Patel as director and Audit Committee chair","bullets":["Sandip Patel appointed as Class III director and Audit Committee chair effective August 8, 2024.","Patel participated in May and July 2024 financings totaling $275,500.","He brings experience in biotech M&A and finance; previously served as General Counsel at WellCare.","No family relationships or arrangements with other directors or officers.","Board cites his advisory background in biopharma for appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-097086","json":"https://secwatch.observer/filing/0000950170-24-097086.json","markdown":"https://secwatch.observer/filing/0000950170-24-097086.md","text":"https://secwatch.observer/filing/0000950170-24-097086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834645/000095017024097086/0000950170-24-097086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834645/000095017024097086/pkbo-20240808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:24:25.939149+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fb36240efe","claim":"Sandip Patel was appointed as Class III Director and Audit Committee Chair at Peak Bio, Inc..","evidence_excerpt":"On August 8, 2024, the Board of Directors of Peak Bio, Inc. (the “Company”) appointed Sandip Patel as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1834645/000095017024097086/0000950170-24-097086-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III Director and Audit Committee Chair"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}